Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene‐Related Demyelinating Peripheral Neuropathy.
Saved in:
| Title: | Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene‐Related Demyelinating Peripheral Neuropathy. |
|---|---|
| Authors: | Jaubert, Pauline (AUTHOR), Loret, Camille (AUTHOR), Stojkovic, Tanya (AUTHOR), Attarian, Shahram (AUTHOR), Bonello‐Palot, Nathalie (AUTHOR), Bouhour, Françoise (AUTHOR), Camdessanche, Jean‐Philippe (AUTHOR), Cassereau, Julien (AUTHOR), Chanson, Jean‐Baptiste (AUTHOR), Cintas, Pascal (AUTHOR), Creange, Alain (AUTHOR), Esselin, Florence (AUTHOR), Genestet, Steeve (AUTHOR), Giordano, Sophie (AUTHOR), Gitiaux, Cyril (AUTHOR), Guillaud‐Bataille, Marine (AUTHOR), Isapof, Arnaud (AUTHOR), Kumaran, Deiva (AUTHOR), Labeyrie, Céline (AUTHOR), Laugel, Vincent (AUTHOR) |
| Source: | European Journal of Neurology. Aug2025, Vol. 32 Issue 8, p1-12. 12p. |
| Subjects: | Charcot-Marie-Tooth disease, Genetic mutation, Genes, Electrophysiology, Phenotypes, Genetic variation, Symptoms, Demyelination |
| Abstract: | Background: Autosomal recessive mutations in the SH3TC2 gene cause Charcot–Marie‐Tooth type 4C (CMT4C) demyelinating peripheral neuropathy. Methods: In this nationwide observational retrospective study involving 27 French University Hospitals, we analyzed the clinical, electrophysiological, and genetic features of 103 patients from 89 families with homozygous and compound heterozygous SH3TC2 gene mutations identified between 2003 and 2023. Results: Mean age was 42 years (2–80), and 49% of patients were female. Mean age at disease onset was 14 years (0–52), 60% of patients started the disease before age 10 years, and 24% after age 20 years. Patients presented with distal motor weakness (93% of cases), sensory loss (86%), foot deformities (83%), scoliosis (73%), proximal limb weakness (40%), cranial nerve involvement (48%), hearing loss (37%), scoliosis‐related respiratory insufficiency (14%), and genitourinary disorders (6%). Half the patients (48%) walked independently before age 50 years, in contrast with only 13% after age 50 years. After age 50 years, 23% of patients were wheelchair‐bound. Nerve conduction studies showed sensorimotor abnormalities within the demyelinating range in all cases. We identified 56 different pathogenic variants in the SH3TC2 gene, including 22 previously undescribed. Patients with two SH3TC2 gene truncating variants had more severe symptoms than patients with one or zero truncating variants. Interpretation: This study shows CMT4C is a severe childhood‐ and adult‐onset demyelinating peripheral neuropathy often associated with scoliosis, hearing loss, and ambulation loss in a significant proportion of patients after age 50 years. Genotype–phenotype correlations suggest two truncating SH3TC2 gene variants cause a more severe phenotype. [ABSTRACT FROM AUTHOR] |
| Copyright of European Journal of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
